Provision of genomic profiling testing of solid tumours and liquid CDX (Foundation One)

This transparency notice is being issued to advise the marketplace that Velindre University NHS Trust are intending to award a two-year contract, with the option to extend for up to a further 12 months, to Roche Diagnostics Limited to undertake genomic profiling testing of solid tumours and liquid CDX using the Foundation One testing process. The total contract value, including the optional extension period, is £121,500.00